AstraZeneca withdraws its COVID-19 vaccine worldwide - Action News
Home WebMail Wednesday, November 13, 2024, 04:40 AM | Calgary | -1.4°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Health

AstraZeneca withdraws its COVID-19 vaccine worldwide

AstraZeneca pulled its COVID vaccine from global markets, citing low demand.

More than 3billion doses of the vaccine supplied during early stage of pandemic

A vial with the AstraZeneca's coronavirus disease (COVID-19) vaccine.
A vial with AstraZeneca's COVID-19 vaccine is pictured in Berlin, in 2021. The company says demand for the vaccine declined as updated competitors became available. (Hannibal Hanschke/Reuters)

AstraZenecasays it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global markets. The vaccine was used early on in the pandemic in many countries, including Canada.

In an update on the European Medicines Agency's website on Wednesday, the regulator said that the approval for Vaxzevria had been withdrawn "at the request of the marketing authorization holder."

More than threebillion doses of the vaccine have been supplied since it first was administered in the United Kingdom in January 2021.

AstraZenecasaid as multiple vaccines against newer variants of the pandemic coronavirus have been developed, there is a surplus. Demand forVaxzevriadeclined and the company said it is no longer being manufactured or supplied.

WATCH | AstraZeneca COVID-19 vaccine pulled:

Vaccine complications explained

6 months ago
Duration 0:41
Dr. Samir Gupta on science working as it should with AstraZeneca's COVID vaccine

Dr. Samir Gupta, a respirologist atSt Michael's Hospital in Toronto, said what's important is that the creation of the AstraZeneca vaccine, testing, roll out,discovery of complications and stopping of vaccine distribution played out as it should for a new pandemic virus.

According to media reports, AstraZeneca previously admitted in court documents that the vaccine can cause rareside-effects such as blood clots and low blood platelet counts.

"Ultimately we can't forget that the virus is worse than the vaccine, even with this complication," Gupta said in an interview on CBC News Network.

AstraZeneca'sapplication to withdraw the vaccine was made onMarch 5 and came into effect on May 7, according to theTelegraph, which first reported the development.

The Serum Institute of India (SII), which producedAstraZeneca's COVID-19 vaccine under the brand name Covishield, stopped manufacturing and supply of the doses since December 2021, an SII spokesperson said.

With files from Reuters

Add some good to your morning and evening.

A vital dose of the week's news in health and medicine, from CBC Health. Delivered to your inbox every Saturday morning.

...

The next issue of CBC Health's Second Opinion will soon be in your inbox.

Discover all CBC newsletters in theSubscription Centre.opens new window

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.